1. Osteoporosis: nonclinical evaluation of drugs intended for treatment Publication: Silver Spring, MD : Center for Drug Evaluation and Research, August 2019 Subject(s): Bone Density Conservation Agents -- therapeutic useDrug Evaluation, Preclinical -- standardsOsteoporosis -- drug therapyAnabolic AgentsBiological ProductsBone DensityResearch DesignToxicity Tests -- standardsAnimalsHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
